The above was said by none other than, Allen Roses, the vice-president of genetics at GlaxoSmithKline (GSK), one of Britain's biggest drugs company. This must come as a big surprise for members of the public but it is an open secret within the drugs industry that most of its products are ineffective in most patients.
In a related issue, Bernama reported that USM is Developing a Genetic-based Dosage Test. Studies had shown that not all medicines and their dosages were suitable for every patient and in this case, the genetics factor played an important role in determining the compatibility of the medicine with the patient. The genetic-based dosage test would enable an individual to know whether the dosage of a particular medicine is suitable for his or her body.
The Funnies, The Spins, The Humourous and The Humourless......
"I do not aim at fusion. Each religion has its own contribution to make to human evolution.
I regard the great faiths of the WORLD as so many branches of a tree, each distinct from the other though having the same source.----Mahatma Ghandhi.
bravenet.com